Clinical Trials Browser

Phase 1/2 × Breast Cancer Lymphedema × Tacrolimus × Clear all

NCT04541290 2022-02-09

Tacrolimus as Treatment of Breast Cancer-Related Lymphedema

Phase 1/2 Completed

Breast Cancer Lymphedema